Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban and vascular endothelial function in non-valvular atrial fibrillation
jRCTs031180347Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of apixaban in Atrial fibrillation (AFib), sponsored by Bristol Myers Squibb. Primary endpoint: vascular endothelial function. Started May 2018; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCTs031180347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180347.